Ribavirin Quantification in Combination Treatment of Chronic Hepatitis C
Ribavirin in combination with alpha 2 interferon is the consensus treatment for chronic hepatitis C. However, recent preliminary pharmacological studies have suggested that the bioavailability of ribavirin displays great interindividual variability. In order to monitor serum ribavirin levels during...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
2003
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC149002/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12499179/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.1.124-129.2003 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|